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Abstract: Glutamate is the most common neurotransmitter in both the central and the peripheral
nervous system. Glutamate is present in all types of neurons in sensory ganglia, and is released not
only from their peripheral and central axon terminals but also from their cell bodies. Consistently,
these neurons express ionotropic and metabotropic receptors, as well as other molecules involved in
the synthesis, transport and release of the neurotransmitter. Primary sensory neurons are the first
neurons in the sensory channels, which receive information from the periphery, and are thus key
players in the sensory transduction and in the transmission of this information to higher centers in
the pathway. These neurons are tightly enclosed by satellite glial cells, which also express several
ionotropic and metabotropic glutamate receptors, and display increases in intracellular calcium
accompanying the release of glutamate. One of the main interests in our group has been the study of
the implication of the peripheral nervous system in sensory-dependent plasticity. Recently, we have
provided novel evidence in favor of morphological changes in first- and second-order neurons of
the trigeminal system after sustained alterations of the sensory input. Moreover, these anatomical
changes are paralleled by several molecular changes, among which those related to glutamatergic
neurotransmission are particularly relevant. In this review, we will describe the state of the art
of the glutamatergic system in sensory ganglia and its involvement in input-dependent plasticity,
a fundamental ground for advancing our knowledge of the neural mechanisms of learning and
adaptation, reaction to injury, and chronic pain.
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1. Introduction
Glutamate is the most abundant excitatory neurotransmitter in both the central and the peripheral
nervous systems, at least in vertebrates. Reasonably, the glutamatergic system has been in the focus of
numerous studies that examined how the nervous system adapts to varying conditions of stimulation
and activity. While this ability to adapt is the basis for what was the earliest description of “plasticity”
applied to the nervous system—“the potential of the brain to adapt to the environment”, according
to Cajal [1]—an unequivocal definition of “neural plasticity” is still lacking [2]. No wonder that the
term is being applied to a wide variety of events, both structural and functional, from single molecules
to complex behaviors. When these events are causally connected, or at least strongly correlated with
sensory signals, it is customary to precede the term “plasticity” with qualifiers such as “experience
dependent” or “sensory input dependent”. The brain is endowed with multiple mechanisms and
capacities to detect and process physicochemical events that reach the sensory receptors, and eventually
use that information to generate behavior. When sensory input is altered, brain signals adapt to the
new situation, but this “physiological” adaptation may not necessarily be referred to as plasticity. It is
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when such alteration exceeds certain fuzzy limits—in terms of intensity, quality and/or duration—that
the ensuing neural events are generally accepted as revealing plastic capacities of the neural tissue.
In a similar vein, developmental events from synapto- or neuritogenesis to brain organogenesis are
left outside the scope of the present review, although in many of them the glutamatergic system plays
important roles [3–6].
Sensory information in the somatosensory system arises in sensory receptors and is conveyed
and processed along several pathways. A distinctive feature in this system is the precise point-to-point
somatotopic pattern adopted by the connections from the receptor sheet through a series of relay
stations, up to the somatosensory cortex. Primary sensory neurons support the transduction of the
stimulus into a neural code, which is then transferred through their neurites to the central nervous
system (CNS). Sensory peripheral afferents consist in the axons of pseudomonopolar neurons whose
cell bodies are located in sensory ganglia, such as the dorsal root ganglia (DRG) or the trigeminal
ganglia (TG). The single neurite that comes out from the soma bifurcates, with one “peripheral” branch
providing sensory innervation to the skin, mucosa and all deep tissues (but the brain and the spinal
cord), and another “central” branch leading into the spinal cord or the brainstem (first relay station of
the pathway). These first relay neurons (second order neurons) project to the ventral posterior and
posterior nuclei of the contralateral thalamus. Finally, thalamic neurons transfer the information to
the somatosensory cortex. Somatosensory information from the face, in particular, is channeled to the
barrel cortex by the trigeminal system (Figure 1).
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Figure 1. Schematic drawing of the trigeminal somatosensory pathway. Each vibrissal follicle in the 
whisker pad is innervated by several peripheral endings of primary afferents. The somata of primary 
sensory neurons are located in the trigeminal ganglion; the central projections of these neurons 
distribute their terminal arbors in the trigeminal nuclei in the brain stem. These nuclei project densely 
and in a highly organized spatial pattern to the contralateral thalamus, which, in turn, projects to the 
somatosensory cortex. Somatosensory information from other bodily regions is collected by primary 
sensory neurons in the dorsal root ganglion, transferred to the spinal cord and lower brain stem, and 
eventually projected to the thalamus and the cortex in a comparable manner (not shown). 
The trigeminal pathway has been extensively used to study developmental processes, when 
structural and functional changes are pronounced, and neural plasticity following alterations of 
sensory input. Once the critical periods of postnatal development are over, sensory cortical areas are 
still capable of a wide range of structural and functional plasticity, expressed from the molecular level 
of channels and receptors to the reorganization of circuits and neural networks. The first studies 
about plasticity in the barrel cortex were made using deprivation paradigms, plucking [7] or 
Figure 1. Schematic drawing of the trigeminal somatosensory pathway. Each vibrissal follicle in
the whisker pad is innervated by several peripheral endings of primary afferents. The somata of
primary sensory neurons are located in the trigeminal ganglion; the central projections of these neurons
distribute their terminal arbors in the trigeminal nuclei in the brain stem. These nuclei project densely
and in a highly organized spatial pattern to the contralateral thalamus, which, in turn, projects to the
somatosensory cortex. Somatosensory information from other bodily regions is collected by primary
sensory neurons in the dorsal root ganglion, transferred to the spinal cord and lower brain stem, and
eventually projected to the thalamus and the cortex in a comparable manner (not shown).
The trigeminal pathway has been extensively used to study developmental processes, when
structural and functional changes are pronounced, and neural plasticity following alterations of
sensory input. Once the critical periods of postnatal development are over, sensory cortical areas
are still capable of a wide range of structural and functional plasticity, expressed from the molecular
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level of channels and receptors to the reorganization of circuits and neural networks. The first
studies about plasticity in the barrel cortex were made using deprivation paradigms, plucking [7]
or trimming [8] some whiskers and leaving others intact. These studies demonstrated the existence
of activity-dependent synaptic plasticity in layers IV and II–III of the barrel cortex, in the former
diminishing with age and in the latter persisting in adult individuals [9]. In general, this plastic
phenomenon after deprivation is characterized by a potentiated response to stimulation of the intact
vibrissae and a reduced response to the deprived ones [10].
A large body of data has been gathered on the involvement of the glutamatergic system in these
phenomena in the cortex. It was shown in the barrel cortex that deprivation responses are mediated
by the induction of Long Term Depression (LTD) in intracortical excitatory synapses established in
pyramidal neurons between layers IV and II–III [11]. In fact, since N-methyl-D-aspartate receptors
(NMDARs) are involved in the development of long term potentiation (LTP), both LTP and LTD
have been considered basic blocks of the synaptic plasticity that is behind experience-dependent and
pain-associated plasticity in many brain regions [12].
In the mechanisms leading to LTP and LTD multiple glutamate receptors (GluRs) are implicated. LTD
is mediated by a slow entry of Ca2+ through NMDARs, which in turn activates protein phosphatases
that mediate the dephosphorylation of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors
(AMPARs) and their internalization [13]. Induction of LTD can also be mediated by metabotropic glutamate
receptors (mGluRs) acting conjointly with presynaptic cannabinoid receptors, which, by retrogradely binding
endocannabinoids released postsynaptically, lower the probability of neurotransmitters release [14,15]. It is
well known that GluRs are also involved in potentiation phenomena, particularly through NMDARs [15],
and blocking NMDA receptors prevents the experience-dependent changes in adult barrel cortex [16].
Experience-dependent plasticity in the CNS is strongly associated with changes in the subunit
composition of glutamate receptors, as has been extensively documented in the cortex [17,18].
Much less is known about these phenomena in subcortical structures, and the involvement of sensory
ganglia in glutamatergic-related plasticity has generally been neglected. Only in disease or injury
related plasticity and the pathology of the peripheral nervous system (PNS) have primary sensory
neurons become frequently visited subjects of study [19–21]. The present review will provide an update
of the glutamatergic system as a main general player in sensory experience-dependent plasticity, and
will focus particularly on the primary sensory afferents and their ganglia, whose role in such plasticity
will surely draw much more attention in the coming years.
2. All Primary Sensory Neurons Use Glutamate and Express Glutamate Receptors
and Transporters
Primary sensory neuron bodies, as well as their axons, vary widely in size, display an assortment
of molecular phenotypes, and likewise show notable differences in functional properties. Neurons
responding only or mainly to noxious stimuli, known as nociceptors, are small and their axons are
unmyelinated or thinly myelinated. The rest of neurons innervating the skin and other superficial
sensory epithelia are larger, sustain myelinated axons, and respond to a variety of mechanical and
thermal stimuli with low threshold [22].
Nociceptive as well as non-nociceptive primary sensory neurons express glutamate and release
it after stimulation, not only from their central and peripheral terminals [23–25], but also from their
cell bodies [26]. The first evidence for the presence of glutamate in sensory neurons of the TG and
the DRG came from early immunocytochemical studies that showed glutamate-immunoreactivity
(IR) in large neurons of the rat DRG and TG but not in autonomic ganglia [27]. Although shortly
thereafter glutamate-IR was also shown in small- and medium-sized neurons of rats and other species,
only a fraction of neurons was described as glutamate-IR. This fraction varied across studies, ranging
from 30% in rat and monkey DRG [28] to 35% in rats, mostly in small neurons [29], up to 65% in cats
DRG [30]. Additionally, these neurons express molecules involved in glutamate signaling including
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proteins involved in its synthesis, transport and release [25,31,32], and others directly related to
glutamatergic neurotransmission, such as ionotropic and metabotropic receptors [33–38].
2.1. Ionotropic Receptors
The terminology for these receptors will follow the NC-IUPHAR recommended nomenclature of
ionotropic glutamate receptor subunits [39].
2.1.1. Kainate
Kainate (KA) receptors are homomeric or heteromeric tetramers consisting of different
arrangements of five subunits, GluK1, GluK2, GluK3, GluK4 and GluK5 (previously known as GluR5,
GluR6, GluR7, KA1 and KA2) that are divided into two groups according to their low and high binding
affinity. Homomeric receptors are composed only of low affinity subunits (GluK1, -2, and -3) whereas
high affinity subunits (GluK4–5) are present in different combinations in heteromeric receptors [40–42].
The presence of presynaptic KA receptors in sensory ganglia has been suggested by reverse
transcriptase PCR (rtPCR) in the TG [43], by transmitter release elicited by activation of KA receptors
in preparations of dissociated DRGs [44,45], and by immunohistochemistry (IHC) [42,46]. It seems
that KA receptors predominate over AMPARs and NMDARs in DRGs, especially in small neurons [46].
In the TG, medium size and small neurons responded to glutamate and KA infusion, and all KA receptor
subunits were detected to some extent using rtPCR [43]. After this initial discovery, it was shown
that GluK1/GluK5 is the preferential composition of these receptors in DRG and TG neurons [43,47],
in contrast with the dominance of the GluK2 subunit in hippocampal and neocortical pyramidal
neurons [48,49]. The expression of GluK1/GluK5 receptors shows variations over time, with an
increase in the first postnatal week, that has been shown to correspond with the period of greatest
developmental plasticity [43].
Low affinity subunits (GluK1, -2, and -3) are expressed presynaptically in primary afferent
terminals in the dorsal horn (DH) of the spinal cord, where they are thought to regulate transmitter
release [42,45,47,50]. From colocalization studies it has been shown that these subunits are present in
both myelinated and unmyelinated primary afferent fibers. Fittingly, the subunits colocalized with
tracers applied to the peripheral nerves: the B subunit of cholera toxin CTB (a marker of myelinated
axons) in the inner part of lamina II and in lamina III, and with the isolectin of Griffonia simplicifolia
IB4 (a marker of unmyelinated axons) in the outer part of lamina II of the DH of the spinal cord [42].
Even though mRNA for GluK2 and GluK3 has been detected in primary afferents, it is unlikely that
these subunits alone contribute to form functional receptors. It seems that GluK1 is the critical subunit
for activation of the heteromeric complex of presynaptic KA receptors since in its absence (GluK1−/−
DRG cells) KA-induced currents are not detected [44,45,47].
The high affinity GluK4 and GluK5 subunits of the KA receptor are expressed in a variety of
terminals, including nociceptive afferents, in laminae I–III. These neurons also expressed the GluK1
subunit [51], which is the most abundant in this location [47]. A large majority of GluK1-IR fibers also
were positive for the purinergic receptor P2X3 indicating that these fibers belong to the non-peptidergic
nociceptive group [51]. GluK1 may form homomeric receptors in some DRG cells or it may combine to
form heteromers with the other 4 subunits [41].
The main role of KA receptors at the presynaptic terminal is thought to be the modulation of
glutamate release [44,47], since their activation on central endings of DRG neurons may result in an
increase or decrease of glutamate release [50]. In addition to their role as ion channels, KA receptors
present in DRG neurons can activate a signaling cascade, acting as metabotropic-like receptors.
This pathway leads to Ca2+ release from intracellular stores and activation of PKC that result in
the inhibition of voltage dependent Ca2+ channels (VGCC). It has been speculated that this signaling
pathway may play a role in KA receptor regulation, helping to maintain the balance of the system [47].
Postsynaptic KA receptors are expressed abundantly throughout the CNS. In the spinal DH,
it seems that their localization is predominantly cytoplasmic, suggesting that these receptors are
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not activated during basal synaptic transmission [21]. In other brain regions KA receptors present
differential expression of some of their subunits: GluK5 has a widespread expression in the brain;
GluK1 is mainly present in interneurons in the cortex, hippocampus and Purkinje cells in the
cerebellum; GluK2 is mostly expressed in hippocampal and cortical pyramidal cells and cerebellar
granule cells; GluK3 has the weakest expression, appearing in layer IV of the cortex and dentate gyrus;
and GluK4 is found in CA3 pyramidal neurons, dentate gyrus, neocortex and Purkinje cells [52].
2.1.2. AMPA
The ionotropic AMPARs may be composed of different combinations of four subunits, designated
GluA1–4 (previously known as GluR1–GluR4) forming tetrameric assemblies of different combinations.
Each subunit has a binding site for glutamate, and the receptor is permeable to various cations including
Ca2+, except when the receptor contains the GluA2 subunit, which renders the channel impermeable
to Ca2+ [44].
All four types of AMPARs subunits have been shown to exist in sensory ganglia and in their
central terminals, exhibiting a differential distribution among neurons of different size. GluA1 seems to
be ubiquitously distributed; it is abundant in TG of male rats, as shown by WB [53] and it is present in
DRG cells and in both myelinated and unmyelinated fibers, with a preference for small cells [44,46,54],
in particular for those expressing substance P (SP) and/or calcitonin gene-related peptide (CGRP),
therefore nociceptive peptidergic fibers [55].
Large DRG neurons were immunostained predominantly by anti-GluA2/3; they distributed
their central axons in laminae III and IV of DH; and took up the axonal tracer CTB. Hence, they
correspond to Aβ and Aδ myelinated fibers that mediate mechanosensitivity and noxious mechanical
and thermal stimuli [36,46,54]. On the other hand, small cells were immunostained predominantly by
anti-GluA4 or anti-GluA2/4; they colocalized with P2X3 and bound IB4, markers of non-peptidergic
and unmyelinated primary nociceptors [36,38]; and their terminals ended in laminae I and II [36,54].
Since GluA4 is expressed in a large number of non-peptidergic primary fibers, which are strongly
associated with neuropathic pain, this subunit may be involved in a presynaptic modulation of
non-peptidergic nociceptors [38].
Postsynaptic AMPARs have a widespread distribution in the entire brain and are clearly involved
in plasticity [56]. Different brain regions are enriched in specific AMPAR subunits. In the DH, all
neurons possess the GluA2 subunit; most superficial DH cells also exhibit receptors containing
the GluA1 subunit; GluA3 is more weekly expressed in laminae I–II than in deeper laminae;
and GluA4 is generally sparse in laminae I–II [21]. It should be noted that AMPARs located in central
terminals of primary sensory axons could develop a postsynaptic function too. It seems that they are
involved in mechanisms of presynaptic inhibition through a phenomenon known as primary afferent
depolarization, traditionally attributed to GABAergic interneurons. In this scenario, endogenously
released glutamate can activate presynaptic AMPARs, probably by a spill-over mechanism producing
local depolarization at the terminals, depression of action potentials and inhibition of glutamate release
from those same terminals [55]. Moreover, AMPAR subunits are transported from the DRG cell bodies
to the periphery, as demonstrated by the presence of AMPAR immunoreactivity in the glabrous skin of
the rat hindpaw [57,58].
2.1.3. NMDA
NMDARs are heteromeric tetramers composed of three subunits, GluN1, GluN2A–D and
GluN3A,B [59]. The presence of the GluN1 is obligatory to form functional receptors. NMDARs subtypes
confer different gating and permeation properties to the channel; the presence of GluN2B gives high
glutamate sensitivity which is even greater when GluN2C/D are present because of its capacity to reduce
the voltage-dependent Mg2+ block, a property that is shared by the GluN3 subunit [33].
Expression of GluN1 subunit was shown by WB, real time PCR (RT-PCR) [37], EM and IHC
in numerous DRG neurons of all sizes, and also in a large number of fibers, mostly myelinated
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A-fiber positive for NF200 [37,38,60]. These fibers were found to terminate more abundantly in
laminae IIi, III and IV, and among them those labeled with CTB predominated over those binding
IB4. No terminal was found to be labeled with CGRP, suggesting that GluN1 is expressed mainly in
presumed low-threshold mechanosensitive afferents [60].
RT-PCR experiments detected mRNA expression of GluN2A–D in DRG neurons, showing GluN2B
and GluN2D higher expression than GluN2A and GluN2C. Proteins of these subunits were also
detected using WB techniques with the exception of GluN2A that was only detected at the mRNA
level [37]. IHC and functional data have confirmed that GluN2B and -D predominate in DRG neurons.
While the most common NMDAR in A fibers seems to be the diheteromer GluN1/GluN2B [37], C fibers
(both peptidergic and non-peptidergic) could also express an additional receptor containing GluN1,
GluN2D, and possibly GluN2C subunits [37,44]. GluN1, GluN2A and GluN2B were also detected by
WB technique in the TG of adult male rats [53].
Experimental ligation of dorsal roots demonstrated that NMDARs are synthesized in the DRG
and transported along the dorsal root towards the central terminals, where they act as presynaptic
receptors in primary afferents modulating afferent input [60,61]. Glutamate seems to be involved in
sensory transduction too, since expression of GluRs and vesicular transporters was demonstrated in
Merkel cells, and GluN1 and GluN2B/A were identified in a zone of the rat sinus hair follicle known
to be densely populated by Merkel cells [62].
Postsynaptic NMDARs have a wide distribution in the CNS and are fundamental for normal
synaptic function and for synaptic plasticity phenomena [13]. The different subunit expression
changes, both during development and in the adult brain, depending on their location. It has been
proved that GluN2B and GluN2D are abundant during early development, forming diheteromeric
receptors together with GluN1, whereas GluN2A or GluN2C subunits are added progressively during
development. While GluN2B is expressed only in the forebrain and GluN2C is enriched in the
cerebellum, GluN2A is ubiquitously expressed in the adult brain [63,64], where they can form not only
diheteromeric receptors but also triheteromeric, including different GluN2 subunits [65].
2.1.4. Delta
The glutamate ionotropic receptor channels delta1 and delta2, now named GluD1 and GluD2, lack
specific ligands, are considered orphan receptors, and their functions remain poorly understood [66,67].
Some recent studies, however, point to a role of GluD2 in the generation of LTD in the cerebellar cortex,
which takes place by controlling the phosphorylation and internalization of the GluA2 subunit in
Purkinje cell dendrites [68]. While the presence of these receptors in DRG or TG has not been examined,
the mRNA coding for GluD1 is strongly expressed in sensory hair cells of the inner ear, as well as in
the primary sensory neurons of the cochlear and vestibular ganglia, and the satellite glial cells in the
cochlear ganglion [69].
2.2. Metabotropic Receptors
The mGluRs form a family of protein G-coupled receptors, which have been classified into
three subgroups according to their molecular structure, signaling pathways and pharmacological
and physiological properties: Group I receptors (mGluR1a–d and mGluR5a–b) are coupled by Gq
proteins to the phospholipase C signal transduction pathway and increase neuronal excitability; Group
II (mGluR2 and mGluR3) are coupled to Gi/Go, which inhibit cAMP formation, decreasing neuronal
excitability; Group III (mGluR4a–b, mGluR6, mGluR7a–b and mGluR8) are also coupled to Gi/Go,
negatively regulate adenylate cyclase activity and decrease excitability [35,70–72]. Group I mGluRs are
mainly localized at the postsynaptic density, whereas Group II and III are primarily, but not exclusively,
located presynaptically, where they serve as auto- and hetero-receptors. In virtue of their synaptic
location and their coupling to G-proteins mGluRs can finely tune the cellular response to glutamate
signaling: postsynaptically they can modulate neuronal excitability, and presynaptically they can act
as auto- and hetero-receptors and modulate neurotransmitter release [70,71].
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In primary sensory ganglia mGluRs, first identified by WB and IHC, are expressed by neurons of
different sizes in the TG [73]. Shortly thereafter, the presence of mRNA for a number of mGluRs was
demonstrated by in situ hybridization in TG and DRG, as well as in numerous regions of the CNS [74].
Further studies showed that all three groups of mGluRs are present in sensory ganglia and in primary
sensory afferents.
2.2.1. Group I
Using immunolabeling, the mGluR5 subunit is present in small to medium size DRG neurons
of rats and humans, as well as in the DH of the spinal cord [72]. In this study, labeling was
markedly heterogeneous, both in intensity, since small diameter DRG neurons were most intensely
stained than larger neurons, and in regional distribution, with strong mGluR5-IR confined within the
superficial layers of the DH. Using IHC and pharmacological approaches, Walker [75] demonstrated
that mGluR5 appears in both the central and the peripheral terminals of primary afferents, and that
most neurons expressing this receptor also expressed the vanilloid receptor 1 (VR1), a marker of
small nociceptive neurons. The intraplantar injection of a mGluR5 agonist was capable of evoking
mechanical hyperalgesia and this effect was prevented by the application of a selective antagonist,
suggesting a functional role of mGluR5 in inflammatory hyperalgesia [74]. It is now widely accepted
that peripheral Group I mGluRs appear to be strategically positioned to activate nociceptors and
modulate sensitization, making them suitable candidates for topical analgesic treatments [71].
Only 7% of DRG cells, most of them small- and medium-sized, express mGluR1, as shown by IHC
and stereological techniques [35]. Approximately half of these cells also coexpress mGluR8 and the
other half express mGluR2/3. There is evidence that both types of Group I receptors are also present
in the peripheral branches of DRG neurons. For instance, mGluR5 is expressed in the Merkel epithelial
receptor cells [76], and in an isolated rat sinus hair follicle preparation a non-competitive mGluR1
antagonist produced profound and long-lasting depression of mechanically evoked firing of Merkel
cell endings [34]. These findings highlight the role of glutamate neurotransmission in peripheral
transduction of sensory stimuli and its involvement in the modulation of the earliest step of sensory
information processing [44].
2.2.2. Group II
mGluR2/3 immunolabeling was found in the soma and in the peripheral and central terminals of
DRG neurons [77]. Approximately 40% to 52% of DRG cells showed mGluR2/3-IR, which was present
almost exclusively in small cells and was coincident with mGluR8-IR in 30% of cells [35,77]. More than
75% of these cells were also labeled with IB4 and their central terminals distributed preferentially in
lamina III, with weaker staining in laminae III and IV. This immunoreactivity was almost abolished
after dorsal rhizotomy, providing further support for the presence of mGluR2/3 in primary afferent
terminals. These receptors may act modulating presynaptically the primary afferent input, particularly
nociceptive input, by negatively regulating glutamate release [71,77].
2.2.3. Group III
It is known that mGluR4, mGluR7 and mGluR8 are widely expressed in nearly all nervous tissues
involved in nociception, suggesting their involvement in the molecular basis of pain [69]. Indeed,
immunostaining of mGluR4a was detected in DRG neurons, particularly in small- to medium-sized
ones, and in a dense patch of terminal-IR in lamina II of the DH [78]. The receptor mGluR7 has been
detected by IHC in neurons of DRG and TG [79]. mGluR7 is specifically expressed in peptidergic and
large DRG neurons in the rat, in which it is often co-expressed with VR1, and is only rarely found in
IB4-positive DRG neurons [80]. It seems that due to its inhibitory nature and presynaptic location,
mGluR7 could negatively modulate glutamate release, possibly acting as an auto-receptor [71,79,80].
The receptor is transported to the central and peripheral axon terminals, since the IR for mGluR7 in the
superficial layers of the DH is reduced after rhizotomy [79], and it builds up at the proximal site after
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sciatic nerve ligation [80]. Using IHC and stereological techniques, it has been shown that mGluR8 is
expressed by 75% of DRG cells of different sizes, having the highest expression among the three groups
of metabotropic receptors (with less prevalence in small neurons). Moreover, there was a substantial
fraction of double-labeled cells expressing both mGluR2/3 and mGluR8 [77]. mGluR8 seems to
be exclusively located on the presynaptic sites of glutamatergic, GABAergic and monoaminergic
terminals, regulating negatively or positively (depending of the cell type) neurotransmitter release [70].
The prevalence of groups II and III in DRG neurons indicate that glutamate could have a substantial
inhibitory effect on primary afferent function, reducing and/or modulating sensory input before
transmission to the spinal cord [71,77].
In sensory ganglia, most studies of mGluRs have been done on DRGs. Only recently the focus
was also directed to the TG. Boye Larsen et al. [81] investigated mGluR expression in the TG of adult
Wistar rats, and found mGluR1-IR in small- and medium-sized neurons of the TG, opening a possible
participation of the receptor in nociceptive transmission. In addition, these authors reported the
expression of mGluR2/3 and mGluR8 in medium- to large-sized neurons.
2.3. Glutamate Transporters
2.3.1. Vesicular Glutamate Transporters
Three vesicular glutamate transporters (VGLUTs) are known: Brain-specific Na+-dependent
inorganic phosphate transporter, VGLUT1, expressed only in a subpopulation of glutamatergic
neurons [82,83]; differentiation-associated Na+-dependent inorganic phosphate transporter, VGLUT2,
highly homologous to VGLUT1,expressed only in neurons and enriched in subcortical regions [82,83];
and H+-dependent glutamate transporter, VGLUT3, structurally and functionally very similar to the
other two [83].
The first study that analyzed the mRNA of VGLUTs in DRGs cells identified VGLUT1
in many neurons (and all the large ones), but failed to detect the other two transporters [84].
More recently, however, mRNA for the three transporters was reported, with the following distribution:
approximately 45% of large to medium size cells expressed VGLUT1, 69% of cells of all sizes expressed
VGLUT2, and 17% of small- and medium-sized cell expressed VGLUT3 [84]. Immunolabeling of the
protein VGLUT1 was observed in 12–13% of mostly large- and medium-sized DRG neurons, while
a large proportion of DRG neurons (65–90%), mostly of small- and medium-size, were positive for
VGLUT2 [31]. VGLUT1 and VGLUT2-IR was also detected in axon terminals in the DH of the spinal
cord, with a different pattern of distribution: VGLUT1 was observed in the deep part of lamina II, and
laminae III and IV, whereas VGLUT2 was located in lamina I and the superficial part of lamina II [83,84].
Few fibers were IR for VGLUT3 in the DH [84,85]. VGLUT1 and VGLUT2-IR were coexpressed in
SP-containing and IB4-binding fibers, indicating that these transporters were present in nociceptive
primary afferents, with a VGLUT2 predominance in unmyelinated fibers [82]. These findings, however,
were not corroborated in a later study, which failed to find IR for VGLUT1 and VGLUT2 in various
peptide-containing axon terminals (CGRP, SP) [86]. Transection experiments were not conclusive, since
dorsal root transection reportedly led to a very marked decrease in VGLUT1 immunopositive fibers,
leaving unaltered the expression of VGLUT2 [84], whilst in another study axotomy of the sciatic nerve
moderately decreased VGLUT3 mRNA expression and did not affect VGLUT1 and VGLUT2 [84,85].
Glutamate transporters were also identified in the TG: mRNA of the three subtypes was detected
by qrtPCR, and IR for VGLUT1 and/or VGLUT2 was found in the 80% of TG neurons [87]. Many of
the cells co-expressed both VGLUT1 and VGLUT2, and, depending on the study, it is VGLUT1 [87] or
VGLUT2 which predominates [83]. This coincidence of VGLUT-IR was also detected in many axon
terminals in the superficial layers of the DH [83]. VGLUT3-IR was also detected in many cells of TG
and was coincident with VGLUT1 expression in most cases [87].
It should be noted that the three vesicular transporters are also variably expressed in the peripheral
branches of the primary sensory neurons. In particular, these transporters have been identified in
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dermal and epidermal nerves of the glabrous skin, in the piloneural complex in hairy skin, and in
a zone of the rat whisker follicle that is densely populated by Merkel cells [31,62].
2.3.2. Excitatory Amino Acid Transporters (EAATs)
EAATs are responsible for the re-uptake of glutamate into cells and it is well established that
under normal conditions, the CNS strongly depends on such re-uptake. Of the five EAATs known,
EAAT1 (also known GLAST) and EAAT2 (GLT1) are expressed in the membrane of glial cells; EAAT3
(EAAC1) and EAAT4 are present in neurons in the CNS; and EAAT5 is exclusively located in the retina.
Several studies have reported that alterations in the expression or activity of EAATs occurs in CNS
disorders, including the central mechanisms for the development and maintenance of neuropathic
pain. Chronic constriction nerve injury (CCI) in rats elicits changes in the expression and uptake
activity of spinal EAATs that contributed to neuropathic pain [88].
Concerning the PNS, little is known about the EAATs distribution in normal conditions, or
following peripheral injuries or pathologies. However, it is known that EAAT1 and -3 are present in
the DRG and the sciatic nerve with a differential cellular distribution: in DRG, EAAT1 and EAAT3 are
located in neurons and satellite glial cells, and EAAT2 is restricted to SGCs, while in the sciatic nerve
all three transporters are present in Schwann cells [89].
To our knowledge, it has not been examined whether these transporters play a role in sensory
input-dependent plasticity.
3. Glutamate Receptors and Transporters in Non-Neuronal Cells in DRG and TG
In addition to sensory neurons, primary sensory ganglia contain a variety of glial and non-glial
cells (Figure 2).
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Figure 2. Diagram showing the cellular co ponents of sensory ganglia: (1) cell body of a primary
sensory neuron; (2) synaptic boutons from the central projection of the sensory neuron, contacting
a second-order neuron in the spinal cord or the trigeminal nuclei of the brain stem; (3) terminal ending
of a peripheral branch of the sensory neuron, contacting a skin receptor (Merkel) cell; (4) satellite
glial cells, tightly enclosing the cell bodies of sensory neurons; (5) Schwann cells and myelin sheaths;
(6) resident T-lymphocyte; (7) resident macrophage; (8) endoneurial and perineurial fibroblast-like cells;
(9) pericyte; (10) capillary endothelial cells; and (11) mast cell. Modified after Avendaño, 2010 [90].
Two types of glial cells abound in sensory ganglia, myelinating and non-myelinating Schwann
cells (SC), and satellite glial cells (SGCs), which tightly shroud the somata of primary sensory neurons,
and participate in maintaining the homeostasis of the microenvironment, neuronal metabolism and
glutamate recycling [91–93]. Other cell types include vascular and connective tissue elements, and
members of the immune system. Several of these cells have been shown to express glutamate
receptors and/or transporters, and therefore are possible targets of glutamate regulation subsequent
to alterations in sensory input (Table 1).
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Table 1. Summary of the glutamate-related genes and proteins that are expressed in DRG and/or TG
neurons and glial cells.
Gene Protein
Neuron
Satellite Glial Cell Schwann Cell Whole Ganglia
Body Central Projection Peripheral Projection
Grik1
Gluk1 +[46,47]
+[47]
+[42] +[58,94] +[94] −[95] * +[44]
Grik2
Gluk2
+[47]
−[26]
+[47]
+[42] +[58,94] +[26,94] +[95] * +[44]
Grik3
Gluk3 +[47]
+[47]
+[42] +[58,94] +[94] +[95] * +[44]
Grik4
Gluk4 +[47] +[51] +[95] * +[44]
Grik5
Gluk5 +[47] +[51] +[95]* +[44]
Gria1
GluA1 +[46,55] +[58] −[54] +[95] * +[96]
Gria2/3
GluA2/3
+[38,46,54,
55] +[36] +[94] + [94] +[95] *
+[96]
+[96]
Gria4
GluA4 +[38,54] +[26,36] +[26,54] +[95] * +[96]
Grin1
GluN1
+[37,46]
+[37,38] +[58,94] +[91,94]
+[95] *
+[95] *
+[96]
+[37]
Grin2A
GluN2A +[26,37] −[97] +[26] +[95] *
+[37,96]
−[37]
Grin2B
GluN2B +[37] +[97] +[91]
+[95] *
+[95] *
+[37,96]
+[37,96]
Grin2C
GluN2C +[37] +[95] *
+[37,98]
+[37]
Grin2D
GluN2D +[37] +[95] *
+[37,98]
+[37]
Grin3A
GluN3A +[95] *
Grin3B
GluN3B +[95] *
Grid1
GluD1
Grid2
GluD2
Grm1
mGluR1 +[35,81] +[81] +[98]
Grm2/3
mGluR2/3 +[35,77,81] +[77] +[77] −[81]
+[96]
+[96]
Grm4
mGluR4 +[99] +[72] +[96]
Grm5
mGluR5 +[72] +[72] +[75] +[96]
Grm6
mGluR6
Grm7
mGluR7 +[74,77] +[74,77] +[96]
Grm8
mGluR8 +[26,35,81] +[26,35,81] +[96]
Slc1a3
EAAT1 +[89] +[89] +[89] +[89] +[89]
Slc1a2
EAAT2 −[89] +[89] +[89] +[89] +[89]
Slc1a1
EAAT3 +[89] +[89] −[89] +[89] +[89]
Slc1a6
EAAT4
Slc1a7
EAAT5
Slc17a7
VGLUT1
+[85]
+[87,100] +[84,100] +[100]
+[85,87]
+[84]
Slc17a6
VGLUT2
+[85]
+[87,100] +[84,100] +[100] +[85,87]
Slc17a8
VGLUT3
+[85]
+[87] +[84] +[31]
+[85,87]
+[87]
* Data derived only from cultured cells.
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3.1. Satellite Glial Cells
These neural crest-derived cells are significantly involved in the regulation of glutamate
neurotransmission. Glutamate enters the SGCs and is converted into glutamine by glutamine
synthetase, which is released and enters the neurons, where it is again transformed into glutamate [92].
Moreover, SGCs are able to release glutamate in response to an increase in intracellular Ca2+
concentration, as shown by fluorimetric assays using acutely isolated TG neurons with adhering
SGCs [93]. Mechanosensory stimuli or nerve stimulation produce an increase in intracellular Ca2+
that spreads not only to neighboring SGCs but also to neighboring neurons, suggesting a possible
involvement of SGCs in the processing and transmission of afferent information [26,91].
All three types of ionotropic glutamate receptors and some of the mGLURs have been observed in
SGCs, mainly by IHC. GluA4 immunolabeling produced a dense staining of SGCs, whereas little or no
staining was detected for subunits GluA2/3 and no staining at all was detected for GluA1 [54]. GluN1,
GluN2A and GluN2B were also immunodetected in SGCs of the rat DRG [26,91]. NMDARs present in
the SGCs have been involved in inflammatory sensitization of nociceptors, by a proposed mechanism
that involves retrograde signaling of glutamate released by spinal cord neurons that activates DRG
NMDARs that are located in the SGCs [19]. There is also evidence that NMDARs, in particular those
containing GluN2B, may participate in a transglial transmission phenomenon occurring at the DRG in
triads formed by neuron-SGC-neuron. If one of these neurons is stimulated with a train of impulses,
there is a delayed response in the other neuron, in a so-called “sandwich synapse” that involves
Ca2+-gated release of ATP in the first synapse (neuron-SGC). This ATP acts on P2Y2 receptors located
in the SGC, which releases glutamate that in turn activates GluN2B-containing NMDARs in the second
neuron (second synapse, SGC-to-neuron) [101].
Carlton and Hargett [35] first demonstrated the presence of mGluRs in SGCs in the PNS, with
the mGluR8 subunit highly expressed and only minimal expression of mGluR1 and mGluR2/3.
In agreement with these findings, mGluR1 and mGluR8—but not mGluR2/3—immunoreactivity was
also found in the SGCs of the TG of adult rats [18]. In addition, the KA receptor GluK2 is expressed
in SGCs [26]. Using Ca2+ imaging and specific agonists and/or antagonists, it was proven that these
GluRs in the SGCs are functional, further supporting their role in regulating glutamate transmission
and neuronal excitability [26,91].
Besides glutamate receptors, SGCs express the glutamate transporters EAAT1, EAAT2 and
EAAT3 [89]. The role of GluRs and transporters in SGCs in the excitability of the ganglion neurons,
sensitization of primary afferent and pain needs more investigation. Growing evidence highlights
the importance of intraganglionic glutamate system in peripheral neuropathies, and SGCs should
be taken into account for understanding the mechanisms of glutamatergic signaling, not only under
physiological conditions, but also for designing new therapies aimed at dealing with PNS disorders.
3.2. Schwann Cells
Cultured SCs express GluN1 and GluN2B, peripheral nerve crush upregulates their expression,
and the survival of SCs becomes compromised when the gene encoding GluN1 (Grin1) is silenced, all
of which points to a significant role of NMDARs for these cells [102]. In addition, ionotropic receptors
have been described in these cells, pointing to an increase of SC signaling after peripheral nerve
injury [95].
Recent studies have shown AMPARs mRNA expression in cultured SCs [94], and functional
AMPARs expressed in developing SCs [103]. However, when SCs mature and become myelinating,
the AMPARs-mediated currents disappear [103].
In CNS axons, activity-dependent glutamate-mediated signaling from axon to myelin has been
demonstrated [104]. Similar mechanisms have not been found in the PNS. However, membrane-bound
glutamate transporters EAAT1, EAAT2 and EAAT3 are expressed in the Schwann cells [89], while
dependent plasticity is unsolved (Figure 3).
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3.5. Pericytes, Endothelial Cells, Smooth Muscle Cells, and Mast Cells
It is well established that glutamate-induced neuronal activity releases second messengers from
neurons or glial cells, thus inducing functional hyperemia. Vasomotor responses from activation of
trigeminal fibers are mediated by CGRP, a peptide that plays a key role in the oligemia associated
with migraines [115]. Pericytes are known to react to neuronal activity by inducing capillary dilatation
when they respond with relaxation to neuron or glial glutamate release [116,117]. Moreover, this
glutamate-mediated signaling can be propagated through gap junctions between pericytes or pericytes
and endothelial cells. Dermal microvascular endothelial cells, in turn, express mGluR1, mGluR4, and
mGluR5. The application of mGluRs agonists increases transendothelial flux, highlighting the role of
glutamate in regulating endothelial barrier function [118]. Nevertheless, to our knowledge, no study
has examined the glutamate-related neurovascular changes secondary to injury or pathology, or their
role in sensory transmission and plasticity.
Mast cells are abundant in DRG and TG but no data exist on their involvement in
input-dependent plasticity.
4. Glutamatergic Receptors and Transporters in Sensory Ganglia Mobilize in Response to
Damage of Peripheral Tissues and Sensory Nerves
The ubiquitous presence of glutamate neurotransmission-related receptors and transporters in
small- and medium-sized primary afferent neurons and fibers makes those molecules natural players
in the establishment and maintenance of altered noxious processing and chronic pain. When peripheral
nerves are injured, robust changes in gene expression and a variety of proteins and other molecules
are detected in DRG neurons. These changes appear in trophic factors, neuropeptides, receptors,
ion channels, signal transduction molecules and synaptic vesicle proteins among others [22,119].
Regarding glutamate neurotransmission, peripheral nerve axotomy brings about changes in GluRs
that persist days or weeks after lesion: mGluR4 and -7 are down-regulated, as well as mGluR7 mRNA,
whilst the AMPA subunits GluA3 and -4 increase their expression [80,119,120]. It is interesting to note
that the down-regulations observed affect metabotropic receptors that inhibit or decrease neuronal
excitability, whereas the up-regulations involve ionotropic receptors mediating an enhancement of
neurotransmitter release and/or neuronal excitability. Overall, these changes may lead to potentiation
of primary afferent input, which is considered to play a significant role in the development of pain
sensitization and perpetuation [121].
After early reports indicated that the subcutaneous administration of ionotropic receptor
agonists elicited allodynia and hyperalgesia, which were attenuated by appropriate antagonists [122],
the involvement of glutamatergic signaling in nociception and pain would be evidenced at all levels
of the peripheral sensory pathway. The stimulation of nociceptors by subcutaneous injections of
capsaicin in the rat hind paw caused a pronounced increase in local glutamate release detected by
HPLC, which was reduced by the concomitant injection of ionotropic receptor and metabotropic
Group I receptor antagonists [123]. In addition, the mechanical allodynia and hyperalgesia that result
from inflammation-related activation of AMPA and KA receptors in glabrous skin of the rat hind
paw was reduced by the specific deletion of the GluA1—but not GluA2—subunit in nociceptors [44].
In the sensory ganglia, signs of altered glutamatergic neurotransmission have been repeatedly found
in several pain models based on nerve injury and/or inflammation. For example, CCI of the sciatic
nerve or the infraorbital nerve of rats produced a significant increase in glutamate immunostaining
and a concomitant increase in the transporter VGLUT2 in DRG, which points to an augmented
release of glutamate due to injury [26]. Likewise, masseter inflammation caused by intramuscular
CFA (complete Freund’s adjuvant) injections in male rats produced an up-regulation of mGluR5 and
a down-regulation of GluN1 in TG [53].
The central terminal branches of primary afferents make up a critical arena where pain signaling
is regulated through modulation of neurotransmitter release. In particular, presynaptic NMDARs
are known to facilitate release of glutamate, SP and BDNF from small (C-type) primary nociceptive
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fibers [21,44]. These receptors in the afferent fiber terminal can play a role as NMDA auto-receptors
and lead to the potentiated release of signaling molecules and, eventually, a state of hyperexcitability.
Moreover, postsynaptic GluK2 may act synergistically with NMDARs to induce spinal LTP, whereas
blockade of NMDARs prevents the primary hyperalgesia induced by C-fiber LTP induction in the
superficial spinal DH [124].
Apart from the key role of different types of GluRs in LTP/LTD-induced spinal cord plasticity,
and in the development or maintenance of pain, peripheral inflammatory hyperalgesia also depends
on glutamate released in DRG leading to an activation of NMDARs in SGCs, which supports a more
global role of DRG as the first modulatory center for certain pain conditions [19]. In addition, deletion
of VGLUT2 in the whole DRG or just in DRG nociceptors avoids most effects induced by pain triggered
by noxious stimuli, peripheral nerve injury or inflammatory pain. If deletion targets VGLUT3 in C-low
threshold DRG mechanoreceptors, mechanical hypersensitivity is abolished. These data show that
DRG VGLUT2 and VGLUT3 are important players in the transmission of several pain modalities [125].
In sum, a growing body of data supports considering the peripheral glutamatergic system
as a promising therapeutic target for pain states, avoiding the risk of interfering with the central
glutamatergic processes. In particular, therapeutic interventions on peripheral NMDARs have
succeeded in alleviating inflammatory or neuropathic pain conditions [126,127].
5. The Glutamatergic System Reacts to Innocuous Manipulation of the Input:
Beyond Lesion-Driven and Pain-Related Effects to Experience-Dependent Plasticity in the Brain
During postnatal development, experience-dependent plasticity strongly depends on the
activity-dependent maturation of glutamatergic synapses concurrent with the establishment of initial
patterns of synaptic connections, and then on the refinement of these connections in adaptation
to sensory input [128]. Postsynaptic AMPA and NMDA receptors are critically involved in these
processes, initially by the insertion of AMPARs containing Ca2+-permeable subunits into “silent”
synapses and a change in the subunit composition of NMDARs, and then by a gradual replacement
of GluA4 by the Ca2+-impermeable GluA2 subunit in AMPA receptors [129,130]. This trafficking is
required for developmental synaptic plasticity, including sensory input-dependent dendritic growth,
and its blockade prevents normal functional and structural development [5,131–134]. Past the critical
period, dendrites and spines retain a lifelong capacity to change. Growth and retraction of terminal
axonal arbors, appearance and disappearance of axonal varicosities and dendritic spines persist,
although decaying with time, on a dominant background of connectional stability in animals living
under standard housing conditions [135–137]. Such changes are boosted in response to prominent and
lasting modifications in the signals coming from the periphery, even when such modifications do not
derive from any tissue damage, but from innocuous and more “natural” sources of input loss or gain.
In adult rodents, these effects have been typically achieved by selectively reducing the active (haptic)
touch from some or all whiskers, and by exposing the animals to sensory enriched environments.
Both procedures are known to induce a variety of structural and functional changes in cortical and
subcortical structures [133,138–148].
Ionotropic glutamate receptors are major players in experience-dependent adult cortical plasticity.
AMPARs, in particular those including GluA1, play a role in enabling experience-dependent and
long-term depression in granular and supragranular layers of deprived barrels in the barrel cortex
in adult mice, since no such depression is observed in GluA1 knock-out mice [10,149]. Likewise,
the expression of GluA1-ct-GFP, a construct that blocks the synaptic delivery of GluA1 during
potentiation prevents experience-driven plasticity [150]. It was only recently that GluA1 was shown to
be a necessary—although not sufficient—factor for the experience-dependent potentiation observed in
single spared whisker preparations in adult mice [151]. In contrast, GluA2 and GluA3, two subunits
that make the AMPAR less permeable to Ca2+, and which are involved in the insertion and stabilization
of AMPARs independently of activity, do not differ from controls in layer IV of the barrel cortex several
weeks after whisker trimming [152]. Postsynaptic NMDARs are also needed for whisker pairing
Int. J. Mol. Sci. 2018, 19, 69 15 of 24
plasticity in the barrel cortex (produced by unilateral trimming of all whiskers, but for two adjacent
ones), which is aborted by the application of an NMDA antagonist [16]. Different types of sensory
deprivation in adult rats, including whisker trimming, lead to a reappearance of “silent” synapses
in the barrel cortex with a re-expression of the GluN2B subunit, which suggests a reactivation of the
conspicuous synaptic plasticity characteristic of postnatal developmental periods [131].
Extended exposure to sensory-enriched environments is known to enhance exploratory behaviors
in adult rats, and to bring about a variety of structural and functional changes in the barrel cortex, such
as expansion of neuronal somata and dendrites, expansion of cortical thickness, increase in number
and size of synapses and so on [144,153–156]. Even short exposures to enrichment induce detectable
up-regulation of genes (mostly immediate-response genes) in the barrel cortex [156,157], but changes
in expression of genes related with synaptic transmission and neuronal structure only occurred after
longer periods of enrichment [158]. At the protein level, GluR expression was found to be regulated
in different forebrain regions by long exposures to enrichment. For example, GluA1 and GluN2B
and -2A significantly increased in whole forebrain homogenates of mice after long-term exposure to
enrichment, and these changes correlated with improvements in behavioral performance on several
memory tasks [159]. In the rat hippocampus, in particular, an increase in GluN2A was observed after
enrichment, together with a decrease in an excitatory amino acid carrier transporter (EAAT3), which
could be related to an increase of glutamate in the synapse [155].
Compared to the glutamatergic mechanisms in dendrites and spines, the participation of
presynaptic structures in activity- and experience-dependent changes in primary sensory cortex
has been less well studied. Sensory deprivation decreases glutamate release probability at the granular
to supragranular synapses in the barrel cortex [160,161]. However, it is unclear whether increased
sensory stimulation enhances glutamate release. It has indeed been proposed that postsynaptic
potentiation (as in LTP) may come with a reduced presynaptic release probability, as a homeostatic
adjustment to the increased input [162,163]. Activation of presynaptic NMDA (and cannabinoid)
receptors results in synaptic depression [164] especially in young animals. This effect is diminished
by normal sensory experience, but it may be reinstalled in adulthood by sensory deprivation [18,33].
The subunit composition of these presynaptic receptors is variable, depending on the brain region
and the developmental stage of the subject. In adults, the 2B subunit predominates in the cortex, and
is also present in the spinal cord and brain stem in combination with subunits 2C and 2D [33,156].
Metabotropic receptors abound in presynaptic locations, both inside and outside active synaptic zones.
These receptors mainly include Group II and Group III types, but some studies have also identified
mGluR1 and -5 in a fraction of synaptic terminals [165]. While substantial advances have been made
in recent years on the roles played by these receptors in the regulation of neurotransmission [161,166],
their involvement in experience-dependent plasticity is practically unknown.
6. The Glutamatergic System and Experience-Dependent Plasticity in the Sensory Ganglia
As reviewed in the above sections, the DRG and the TG are rich in glutamate-related receptors
and transporters, as are the primary sensory neurons and other cells that these ganglia contain
(Table 1). For a long time, mature primary sensory neurons were considered relatively passive
relays for transferring sensory information to central nervous structures. The massive cellular and
molecular changes in these neurons that followed axotomy or other nerve injuries [22,119,167–169]
were considered to represent adaptive, self-protective and regenerative responses of the damaged
cell. Even when chronic pain conditions developed after nerve or peripheral tissue injury, the primary
sensory neuron was easily dismissed as a merely ancillary or subordinate actor [170]. Not surprisingly,
sensory ganglia have been practically overlooked in experience-dependent plasticity studies.
Recent studies by our group [96,171], however, showed that the terminal afferents of primary
sensory neurons, and the expression of many glutamate-related genes in the adult TG of rats change
after chronic exposure to an enriched environment, or repeated unilateral whisker trimming. While
the explanation of those molecular changes was complicated by the existence of lateral asymmetries in
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a good number of genes, some conclusions emerged from this study: (1) Environmental enrichment led
to a reduction of metabotropic receptors-encoding genes on the right side, which suggests a facilitation
of synaptic transmission at least on the right side. (2) The gene encoding the subunit 2B of the NMDA
receptor decreases on the right side and does not change on the left, but the protein significantly
increases on both sides after enrichment. This finding parallels the increased contents in this subunit
in the forebrain after long-term exposure to enrichment [159]. (3) The AMPA receptor subunits
GluA1 and GluA4 are reduced on both sides following enrichment, which could be interpreted to
favor synaptic facilitation [98]. (4) Unilateral haptic deprivation by repeated whisker trimming on
the right side gives rise to bilateral modifications in several glutamate-related genes and receptors;
overall, these changes consisted in an extensive upregulation of gene expression in the right TG, and
a more limited downregulation in the left TG. (5) Increases in gene expression on the right side after
deprivation mainly involved the genes encoding GluA1, GluA2, GluN2B and mGluR3, with variable
changes in protein content. (6) Gria4, the gene coding for GluA4, was bilaterally upregulated in TG
after unilateral deprivation, with significant increases of the subunit protein only on the right TG.
(7) GluN2B significantly increased in the right TG and did not vary in the left, where its encoding gene
Grin2B was markedly down-regulated.
Some of these gene and protein changes paralleled effects reported after peripheral nerve lesions
or chronic pain conditions [38,96,120], and even some of the long-term molecular changes observed
in CNS after deprivation or enrichment (see Section 5). However, our results just scratch the surface
of really understanding the mechanisms whereby sensory ganglia react and adapt to the changing
conditions imposed by an altered sensory input. It goes without saying that: (1) sensory ganglia are
complex structures that lodge a variety of cells—not just neurons—some of which utilize glutamate
receptors or transporters; and (2) only cell bodies and a minor part of their neurites are located in the
ganglia, thus whatever gene or protein change is detected in the ganglia might be due to phenomena
taking place far away from them.
7. Concluding Note
It seems reasonable to speculate that the numerous molecular changes in sensory ganglia that
result from manipulations of the sensory input should be at least instrumental to determine the
functional and structural changes that appear further up in the sensory pathway. To what extent these
relationships may be causal is unexplored, and probably difficult to demonstrate. However, it may
be affirmed that the molecular, functional and structural plasticity of primary sensory neurons and
their accompanying cells lay a fundamental ground for adaptation strategies, learning processes and
recovery from lesions. Not a minor issue, only by better understanding how these early stations of
sensory processing react to input distortions could new and more effective chronic pain therapies
be developed.
Acknowledgments: This work was supported by Grants BFU2012-39960 and BFU2015-66941R from Spain’s
Ministerio de Economía y Competitividad/Fondo Europeo para el Desarrollo Regional (MINECO/FEDER).
Author Contributions: Carlos Avendaño and Pilar Negredo. conceived and designed the review. Carlos Avendaño
drew the pictures. Julia Fernández-Montoya, Carlos Avendaño and Pilar Negredo wrote the paper. Pilar Negredo
made the final revision of the manuscript.
Conflicts of Interest: The authors declare no conflict of interest.
References
1. DeFelipe, J. Brain plasticity and mental processes: Cajal again. Nat. Rev. Neurosci. 2006, 7, 811–817. [CrossRef]
[PubMed]
2. Will, B.; Dalrymple-Alford, J.; Wolff, M.; Cassel, J.C. Reflections on the use of the concept of plasticity
in neurobiology. Translation and adaptation by Bruno Will, John Dalrymple-Alford, Mathieu Wolff and
Jean-Christophe Cassel from J. Paillard, J Psychol 1976;1:33–47. Behav. Brain Res. 2008, 192, 7–11. [CrossRef]
[PubMed]
Int. J. Mol. Sci. 2018, 19, 69 17 of 24
3. Mattson, M.P. Neurotransmitters in the regulation of neuronal cytoarchitecture. Brain Res. 1988, 472, 179–212.
[CrossRef]
4. Harris, K.M. Structure, development, and plasticity of dendritic spines. Curr. Opin. Neurobiol. 1999, 9, 343–348.
[CrossRef]
5. Cline, H.; Haas, K. The regulation of dendritic arbor development and plasticity by glutamatergic synaptic
input: A review of the synaptotrophic hypothesis. J. Physiol. 2008, 586, 1509–1517. [CrossRef] [PubMed]
6. Fedder, K.N.; Sabo, S.L. On the Role of Glutamate in Presynaptic Development: Possible Contributions of
Presynaptic NMDA Receptors. Biomolecules 2015, 5, 3448–3466. [CrossRef] [PubMed]
7. Kossut, M.; Hand, P. Early development of changes in cortical representation of C3 vibrissa following
neonatal denervation of surrounding vibrissa receptors: A 2-deoxyglucose study in the rat. Neurosci. Lett.
1984, 46, 7–12. [CrossRef]
8. Simons, D.J.; Land, P.W. Early experience of tactile stimulation influences organization of somatic sensory
cortex. Nature 1987, 326, 694–697. [CrossRef] [PubMed]
9. Fox, K. A critical period for experience-dependent synaptic plasticity in rat barrel cortex. J. Neurosci. 1992,
12, 1826–1838. [PubMed]
10. Wright, N.; Glazewski, S.; Hardingham, N.; Phillips, K.; Pervolaraki, E.; Fox, K. Laminar analysis of the
role of GluR1 in experience-dependent and synaptic depression in barrel cortex. Nat. Neurosci. 2008, 11,
1140–1142. [CrossRef] [PubMed]
11. Glazewski, S.; Fox, K. Time course of experience-dependent synaptic potentiation and depression in barrel
cortex of adolescent rats. J. Neurophysiol. 1996, 75, 1714–1729. [CrossRef] [PubMed]
12. Zhuo, M. Contribution of synaptic plasticity in the insular cortex to chronic pain. Neuroscience 2016, 338,
220–229. [CrossRef] [PubMed]
13. Luscher, C.; Malenka, R.C. NMDA receptor-dependent long-term potentiation and long-term depression
(LTP/LTD). Cold Spring Harb. Perspect. Biol. 2012, 4. [CrossRef] [PubMed]
14. Castillo, P.E.; Younts, T.J.; Chavez, A.E.; Hashimotodani, Y. Endocannabinoid signaling and synaptic function.
Neuron 2012, 76, 70–81. [CrossRef] [PubMed]
15. Feldman, D.E. Synaptic mechanisms for plasticity in neocortex. Annu. Rev. Neurosci. 2009, 32, 33–55. [CrossRef]
[PubMed]
16. Rema, V.; Armstrong-James, M.; Ebner, F.F. Experience-dependent plasticity of adult rat S1 cortex requires
local NMDA receptor activation. J. Neurosci. 1998, 18, 10196–10206. [PubMed]
17. Tropea, D.; Van Wart, A.; Sur, M. Molecular mechanisms of experience-dependent plasticity in visual cortex.
Philos. Trans. R. Soc. Lond. B Biol. Sci. 2009, 364, 341–355. [CrossRef] [PubMed]
18. Larsen, R.S.; Smith, I.T.; Miriyala, J.; Han, J.E.; Corlew, R.J.; Smith, S.L.; Philpot, B.D. Synapse-specific control
of experience-dependent plasticity by presynaptic NMDA receptors. Neuron 2014, 83, 879–893. [CrossRef]
[PubMed]
19. Ferrari, L.F.; Lotufo, C.M.; Araldi, D.; Rodrigues, M.A.; Macedo, L.P.; Ferreira, S.H.; Parada, C.A.
Inflammatory sensitization of nociceptors depends on activation of NMDA receptors in DRG satellite
cells. Proc. Natl. Acad. Sci. USA 2014, 111, 18363–18368. [CrossRef] [PubMed]
20. Carozzi, V.; Marmiroli, P.; Cavaletti, G. Focus on the role of Glutamate in the pathology of the peripheral
nervous system. CNS Neurol. Disord. Drug Targets 2008, 7, 348–360. [CrossRef] [PubMed]
21. Larsson, M.; Broman, J. Synaptic plasticity and pain: Role of ionotropic glutamate receptors. Neuroscientist
2011, 17, 256–273. [CrossRef] [PubMed]
22. Lawson, S.N. The Peripheral Sensory Nervous System: Dorsal Root Ganglion Neurons. In Peripheral Neuropathy;
Dyck, P.J., Thomas, P.K., Saunders, W.B., Eds.; Elsevier Inc.: New York, NY, USA, 2005; pp. 163–202.
23. Bae, Y.C.; Ihn, H.J.; Park, M.J.; Ottersen, O.P.; Moritani, M.; Yoshida, A.; Shigenaga, Y. Identification of
signal substances in synapses made between primary afferents and their associated axon terminals in the rat
trigeminal sensory nuclei. J. Comp. Neurol. 2000, 418, 299–309. [CrossRef]
24. DeGroot, J.; Zhou, S.; Carlton, S.M. Peripheral glutamate release in the hindpaw following low and high
intensity sciatic stimulation. Neuroreport 2000, 11, 497–502. [CrossRef] [PubMed]
25. Miller, K.E.; Hoffman, E.M.; Sutharshan, M.; Schechter, R. Glutamate pharmacology and metabolism in
peripheral primary afferents: Physiological and pathophysiological mechanisms. Pharmacol. Ther. 2011, 130,
283–309. [CrossRef] [PubMed]
Int. J. Mol. Sci. 2018, 19, 69 18 of 24
26. Kung, L.H.; Gong, K.; Adedoyin, M.; Ng, J.; Bhargava, A.; Ohara, P.T.; Jasmin, L. Evidence for glutamate as
a neuroglial transmitter within sensory ganglia. PLoS ONE 2013, 8, e68312. [CrossRef] [PubMed]
27. Wanaka, A.; Shiotani, Y.; Kiyama, H.; Matsuyama, T.; Kamada, T.; Shiosaka, S.; Tohyama, M. Glutamate-like
immunoreactive structures in primary sensory neurons in the rat detected by a specific antiserum against
glutamate. Exp. Brain Res. 1987, 65, 691–694. [CrossRef] [PubMed]
28. Battaglia, G.; Rustioni, A. Coexistence of glutamate and substance P in dorsal root ganglion neurons of the
rat and monkey. J. Comp. Neurol. 1988, 277, 302–312. [CrossRef] [PubMed]
29. Kai-Kai, M.A. Cytochemistry of the trigeminal and dorsal root ganglia and spinal cord of the rat.
Comp. Biochem. Physiol. A Comp. Physiol. 1989, 93, 183–193. [CrossRef]
30. Stoyanova, I.; Dandov, A.; Lazarov, N.; Chouchkov, C. GABA- and glutamate-immunoreactivity in sensory
ganglia of cat: A quantitative analysis. Arch. Physiol. Biochem. 1998, 106, 362–369. [CrossRef] [PubMed]
31. Brumovsky, P.R. VGLUTs in Peripheral Neurons and the Spinal Cord: Time for a Review. ISRN Neurol. 2013,
2013, 829753. [CrossRef] [PubMed]
32. Carozzi, V.A.; Zoia, C.P.; Maggioni, D.; Verga, E.; Marmiroli, P.; Ferrarese, C.; Cavaletti, G. Expression,
distribution and glutamate uptake activity of high affinity-excitatory aminoacid transporters in in vitro
cultures of embryonic rat dorsal root ganglia. Neuroscience 2011, 192, 275–284. [CrossRef] [PubMed]
33. Bouvier, G.; Bidoret, C.; Casado, M.; Paoletti, P. Presynaptic NMDA receptors: Roles and rules. Neuroscience
2015, 311, 322–340. [CrossRef] [PubMed]
34. Cahusac, P.M.; Mavulati, S.C. Non-competitive metabotropic glutamate 1 receptor antagonists block activity
of slowly adapting type I mechanoreceptor units in the rat sinus hair follicle. Neuroscience 2009, 163, 933–941.
[CrossRef] [PubMed]
35. Carlton, S.M.; Hargett, G.L. Colocalization of metabotropic glutamate receptors in rat dorsal root ganglion
cells. J. Comp. Neurol. 2007, 501, 780–789. [CrossRef] [PubMed]
36. Lu, C.R.; Hwang, S.J.; Phend, K.D.; Rustioni, A.; Valtschanoff, J.G. Primary afferent terminals in spinal cord
express presynaptic AMPA receptors. J. Neurosci. 2002, 22, 9522–9529. [PubMed]
37. Marvizon, J.C.; McRoberts, J.A.; Ennes, H.S.; Song, B.; Wang, X.; Jinton, L.; Corneliussen, B.; Mayer, E.A.
Two N-methyl-D-aspartate receptors in rat dorsal root ganglia with different subunit composition and
localization. J. Comp. Neurol. 2002, 446, 325–341. [CrossRef] [PubMed]
38. Willcockson, H.; Valtschanoff, J. AMPA and NMDA glutamate receptors are found in both peptidergic and
non-peptidergic primary afferent neurons in the rat. Cell Tissue Res. 2008, 334, 17–23. [CrossRef] [PubMed]
39. Collingridge, G.L.; Olsen, R.W.; Peters, J.; Spedding, M. A nomenclature for ligand-gated ion channels.
Neuropharmacology 2009, 56, 2–5. [CrossRef] [PubMed]
40. Fletcher, E.J.; Lodge, D. New developments in the molecular pharmacology of alpha-amino-3-hydroxy-5-methyl-
4-isoxazole propionate and kainate receptors. Pharmacol. Ther. 1996, 70, 65–89. [CrossRef]
41. Kerchner, G.A.; Wilding, T.J.; Huettner, J.E.; Zhuo, M. Kainate receptor subunits underlying presynaptic
regulation of transmitter release in the dorsal horn. J. Neurosci. 2002, 22, 8010–8017. [PubMed]
42. Hwang, S.J.; Rustioni, A.; Valtschanoff, J.G. Kainate receptors in primary afferents to the rat gracile nucleus.
Neurosci. Lett. 2001, 312, 137–140. [CrossRef]
43. Sahara, Y.; Noro, N.; Iida, Y.; Soma, K.; Nakamura, Y. Glutamate receptor subunits GluR5 and KA-2 are
coexpressed in rat trigeminal ganglion neurons. J. Neurosci. 1997, 17, 6611–6620. [PubMed]
44. Bardoni, R. Role of presynaptic glutamate receptors in pain transmission at the spinal cord level.
Curr. Neuropharmacol. 2013, 11, 477–483. [CrossRef] [PubMed]
45. Kerchner, G.A.; Wilding, T.J.; Li, P.; Zhuo, M.; Huettner, J.E. Presynaptic kainate receptors regulate spinal
sensory transmission. J. Neurosci. 2001, 21, 59–66. [PubMed]
46. Sato, K.; Kiyama, H.; Park, H.T.; Tohyama, M. AMPA, KA and NMDA receptors are expressed in the rat
DRG neurones. Neuroreport 1993, 4, 1263–1265. [CrossRef] [PubMed]
47. Rozas, J.L. Metabotropic actions of kainate receptors in dorsal root ganglion cells. Adv. Exp. Med. Biol. 2011,
717, 69–80. [PubMed]
48. Munoz, A.; Woods, T.M.; Jones, E.G. Laminar and cellular distribution of AMPA, kainate, and NMDA
receptor subunits in monkey sensory-motor cortex. J. Comp. Neurol. 1999, 407, 472–490. [CrossRef]
49. Paternain, A.V.; Herrera, M.T.; Nieto, M.A.; Lerma, J. GluR5 and GluR6 kainate receptor subunits coexist in
hippocampal neurons and coassemble to form functional receptors. J. Neurosci. 2000, 20, 196–205. [PubMed]
Int. J. Mol. Sci. 2018, 19, 69 19 of 24
50. Rustioni, A. Modulation of sensory input to the spinal cord by presynaptic ionotropic glutamate receptors.
Arch. Ital. Biol. 2005, 143, 103–112. [PubMed]
51. Lucifora, S.; Willcockson, H.H.; Lu, C.R.; Darstein, M.; Phend, K.D.; Valtschanoff, J.G.; Rustioni, A.
Presynaptic low- and high-affinity kainate receptors in nociceptive spinal afferents. Pain 2006, 120, 97–105.
[CrossRef] [PubMed]
52. Lerma, J.; Marques, J.M. Kainate receptors in health and disease. Neuron 2013, 80, 292–311. [CrossRef]
[PubMed]
53. Lee, J.; Ro, J.Y. Differential regulation of glutamate receptors in trigeminal ganglia following masseter
inflammation. Neurosci. Lett. 2007, 421, 91–95. [CrossRef] [PubMed]
54. Tachibana, M.; Wenthold, R.J.; Morioka, H.; Petralia, R.S. Light and electron microscopic immunocytochemical
localization of AMPA-selective glutamate receptors in the rat spinal cord. J. Comp. Neurol. 1994, 344, 431–454.
[CrossRef] [PubMed]
55. Lee, C.J.; Bardoni, R.; Tong, C.K.; Engelman, H.S.; Joseph, D.J.; Magherini, P.C.; MacDermott, A.B. Functional
expression of AMPA receptors on central terminals of rat dorsal root ganglion neurons and presynaptic
inhibition of glutamate release. Neuron 2002, 35, 135–146. [CrossRef]
56. Santos, S.D.; Carvalho, A.L.; Caldeira, M.V.; Duarte, C.B. Regulation of AMPA receptors and synaptic
plasticity. Neuroscience 2009, 158, 105–125. [CrossRef] [PubMed]
57. Carlton, S.M.; Hargett, G.L.; Coggeshall, R.E. Localization and activation of glutamate receptors in
unmyelinated axons of rat glabrous skin. Neurosci. Lett. 1995, 197, 25–28. [CrossRef]
58. Coggeshall, R.E.; Carlton, S.M. Ultrastructural analysis of NMDA, AMPA, and kainate receptors on
unmyelinated and myelinated axons in the periphery. J. Comp. Neurol. 1998, 391, 78–86. [CrossRef]
59. Dingledine, R.; Borges, K.; Bowie, D.; Traynelis, S.F. The glutamate receptor ion channels. Pharmacol. Rev.
1999, 51, 7–61. [PubMed]
60. Lu, C.R.; Hwang, S.J.; Phend, K.D.; Rustioni, A.; Valtschanoff, J.G. Primary afferent terminals that express
presynaptic NR1 in rats are mainly from myelinated, mechanosensitive fibers. J. Comp. Neurol. 2003, 460,
191–202. [CrossRef] [PubMed]
61. Liu, H.; Wang, H.; Sheng, M.; Jan, L.Y.; Jan, Y.N.; Basbaum, A.I. Evidence for presynaptic
N-methyl-D-aspartate autoreceptors in the spinal cord dorsal horn. Proc. Natl. Acad. Sci. USA 1994,
91, 8383–8387. [CrossRef] [PubMed]
62. Hitchcock, I.S.; Genever, P.G.; Cahusac, P.M. Essential components for a glutamatergic synapse between
Merkel cell and nerve terminal in rats. Neurosci. Lett. 2004, 362, 196–199. [CrossRef] [PubMed]
63. Cull-Candy, S.G.; Leszkiewicz, D.N. Role of distinct NMDA receptor subtypes at central synapses. Sci. STKE
2004, 2004, re16. [CrossRef] [PubMed]
64. Kohr, G. NMDA receptor function: Subunit composition versus spatial distribution. Cell Tissue Res. 2006,
326, 439–446. [CrossRef] [PubMed]
65. Paoletti, P.; Bellone, C.; Zhou, Q. NMDA receptor subunit diversity: Impact on receptor properties, synaptic
plasticity and disease. Nat. Rev. Neurosci. 2013, 14, 383–400. [CrossRef] [PubMed]
66. Villmann, C.; Strutz, N.; Morth, T.; Hollmann, M. Investigation by ion channel domain transplantation of
rat glutamate receptor subunits, orphan receptors and a putative NMDA receptor subunit. Eur. J. Neurosci.
1999, 11, 1765–1778. [CrossRef] [PubMed]
67. Collingridge, G.L.; Olsen, R.; Peters, J.A.; Spedding, M. Ligand gated ion channels. Neuropharmacology 2009,
56, 1. [CrossRef] [PubMed]
68. Kohda, K.; Kakegawa, W.; Yuzaki, M. Unlocking the secrets of the delta2 glutamate receptor: A gatekeeper
for synaptic plasticity in the cerebellum. Commun. Integr. Biol. 2013, 6, e26466. [CrossRef] [PubMed]
69. Safieddine, S.; Wenthold, R.J. The glutamate receptor subunit delta1 is highly expressed in hair cells of the
auditory and vestibular systems. J. Neurosci. 1997, 17, 7523–7531. [PubMed]
70. Palazzo, E.; de Novellis, V.; Rossi, F.; Maione, S. Supraspinal metabotropic glutamate receptor subtype 8:
A switch to turn off pain. Amino Acids 2014, 46, 1441–1448. [CrossRef] [PubMed]
71. Palazzo, E.; Marabese, I.; de Novellis, V.; Rossi, F.; Maione, S. Supraspinal metabotropic glutamate receptors:
A target for pain relief and beyond. Eur. J. Neurosci. 2014, 39, 444–454. [CrossRef] [PubMed]
72. Valerio, A.; Rizzonelli, P.; Paterlini, M.; Moretto, G.; Knopfel, T.; Kuhn, R.; Memo, M.; Spano, P. mGluR5
metabotropic glutamate receptor distribution in rat and human spinal cord: A developmental study.
Neurosci. Res. 1997, 28, 49–57. [CrossRef]
Int. J. Mol. Sci. 2018, 19, 69 20 of 24
73. Araki, T.; Kenimer, J.G.; Nishimune, A.; Sugiyama, H.; Yoshimura, R.; Kiyama, H. Identification of the
metabotropic glutamate receptor-1 protein in the rat trigeminal ganglion. Brain Res. 1993, 627, 341–344.
[CrossRef]
74. Ohishi, H.; Akazawa, C.; Shigemoto, R.; Nakanishi, S.; Mizuno, N. Distributions of the mRNAs for
L-2-amino-4-phosphonobutyrate-sensitive metabotropic glutamate receptors, mGluR4 and mGluR7, in
the rat brain. J. Comp. Neurol. 1995, 360, 555–570. [CrossRef] [PubMed]
75. Walker, K.; Reeve, A.; Bowes, M.; Winter, J.; Wotherspoon, G.; Davis, A.; Schmid, P.; Gasparini, F.; Kuhn, R.;
Urban, L. mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral
sensory neurones mediate inflammatory hyperalgesia. Neuropharmacology 2001, 40, 10–19. [CrossRef]
76. Maksimovic, S.; Baba, Y.; Lumpkin, E.A. Neurotransmitters and synaptic components in the Merkel
cell-neurite complex, a gentle-touch receptor. Ann. N. Y. Acad. Sci. 2013, 1279, 13–21. [CrossRef] [PubMed]
77. Carlton, S.M.; Hargett, G.L.; Coggeshall, R.E. Localization of metabotropic glutamate receptors 2/3 on
primary afferent axons in the rat. Neuroscience 2001, 105, 957–969. [CrossRef]
78. Azkue, J.J.; Liu, X.G.; Zimmermann, M.; Sandkuhler, J. Induction of long-term potentiation of C fibre-evoked
spinal field potentials requires recruitment of group I, but not group II/III metabotropic glutamate receptors.
Pain 2003, 106, 373–379. [CrossRef] [PubMed]
79. Li, J.L.; Ohishi, H.; Kaneko, T.; Shigemoto, R.; Neki, A.; Nakanishi, S.; Mizuno, N. Immunohistochemical
localization of a metabotropic glutamate receptor, mGluR7, in ganglion neurons of the rat; with special
reference to the presence in glutamatergic ganglion neurons. Neurosci. Lett. 1996, 204, 9–12. [CrossRef]
80. Li, J.Y.; Wang, X.; Ji, P.T.; Li, X.F.; Guan, G.H.; Jiang, X.S.; Zhou, G.S.; Hua, F.; Wang, N. Peripheral nerve injury
decreases the expression of metabolic glutamate receptor 7 in dorsal root ganglion neurons. Neurosci. Lett.
2012, 531, 52–56. [CrossRef] [PubMed]
81. Boye Larsen, D.; Ingemann Kristensen, G.; Panchalingam, V.; Laursen, J.C.; Norgaard Poulsen, J.; Skallerup
Andersen, M.; Kandiah, A.; Gazerani, P. Investigating the expression of metabotropic glutamate receptors
in trigeminal ganglion neurons and satellite glial cells: Implications for craniofacial pain. J. Recept. Signal.
Transduct. Res. 2014, 34, 261–269. [CrossRef] [PubMed]
82. El Mestikawy, S.; Wallen-Mackenzie, A.; Fortin, G.M.; Descarries, L.; Trudeau, L.E. From glutamate co-release
to vesicular synergy: Vesicular glutamate transporters. Nat. Rev. Neurosci. 2011, 12, 204–216. [CrossRef]
[PubMed]
83. Li, J.L.; Fujiyama, F.; Kaneko, T.; Mizuno, N. Expression of vesicular glutamate transporters, VGluT1 and
VGluT2, in axon terminals of nociceptive primary afferent fibers in the superficial layers of the medullary
and spinal dorsal horns of the rat. J. Comp. Neurol. 2003, 457, 236–249. [CrossRef] [PubMed]
84. Oliveira, A.L.; Hydling, F.; Olsson, E.; Shi, T.; Edwards, R.H.; Fujiyama, F.; Kaneko, T.; Hokfelt, T.;
Cullheim, S.; Meister, B. Cellular localization of three vesicular glutamate transporter mRNAs and proteins
in rat spinal cord and dorsal root ganglia. Synapse 2003, 50, 117–129. [CrossRef] [PubMed]
85. Malet, M.; Vieytes, C.A.; Lundgren, K.H.; Seal, R.P.; Tomasella, E.; Seroogy, K.B.; Hokfelt, T.; Gebhart, G.F.;
Brumovsky, P.R. Transcript expression of vesicular glutamate transporters in lumbar dorsal root ganglia and
the spinal cord of mice—Effects of peripheral axotomy or hindpaw inflammation. Neuroscience 2013, 248,
95–111. [CrossRef] [PubMed]
86. Morris, J.L.; Konig, P.; Shimizu, T.; Jobling, P.; Gibbins, I.L. Most peptide-containing sensory neurons lack
proteins for exocytotic release and vesicular transport of glutamate. J. Comp. Neurol. 2005, 483, 1–16.
[CrossRef] [PubMed]
87. Honma, S.; Kato, A.; Shi, L.; Yatani, H.; Wakisaka, S. Vesicular glutamate transporter immunoreactivity in
the periodontal ligament of the rat incisor. Anat. Rec. 2012, 295, 160–166. [CrossRef] [PubMed]
88. Sung, B.; Lim, G.; Mao, J. Altered expression and uptake activity of spinal glutamate transporters after nerve
injury contribute to the pathogenesis of neuropathic pain in rats. J. Neurosci. 2003, 23, 2899–2910. [PubMed]
89. Carozzi, V.A.; Canta, A.; Oggioni, N.; Ceresa, C.; Marmiroli, P.; Konvalinka, J.; Zoia, C.; Bossi, M.; Ferrarese, C.;
Tredici, G.; et al. Expression and distribution of ‘high affinity’ glutamate transporters GLT1, GLAST, EAAC1
and of GCPII in the rat peripheral nervous system. J. Anat. 2008, 213, 539–546. [CrossRef] [PubMed]
90. Avendano, C. El Concierto Celular del Dolor Neuropático in Sociedad Española de Bioquímica y Biología Molecular
2010; Sociedad Española de Bioquímica y Biología Molecular: Madrid, Spain, 2010.
Int. J. Mol. Sci. 2018, 19, 69 21 of 24
91. Castillo, C.; Norcini, M.; Martin Hernandez, L.A.; Correa, G.; Blanck, T.J.; Recio-Pinto, E. Satellite glia cells
in dorsal root ganglia express functional NMDA receptors. Neuroscience 2013, 240, 135–146. [CrossRef]
[PubMed]
92. Miller, K.E.; Richards, B.A.; Kriebel, R.M. Glutamine-, glutamine synthetase-, glutamate dehydrogenase- and
pyruvate carboxylase-immunoreactivities in the rat dorsal root ganglion and peripheral nerve. Brain Res.
2002, 945, 202–211. [CrossRef]
93. Wagner, L.; Warwick, R.A.; Pannicke, T.; Reichenbach, A.; Grosche, A.; Hanani, M. Glutamate release from
satellite glial cells of the murine trigeminal ganglion. Neurosci. Lett. 2014, 578, 143–147. [CrossRef] [PubMed]
94. Kinkelin, I.; Brocker, E.B.; Koltzenburg, M.; Carlton, S.M. Localization of ionotropic glutamate receptors in
peripheral axons of human skin. Neurosci. Lett. 2000, 283, 149–152. [CrossRef]
95. Campana, W.M.; Mantuano, E.; Azmoon, P.; Henry, K.; Banki, M.A.; Kim, J.H.; Pizzo, D.P.; Gonias, S.L.
Ionotropic glutamate receptors activate cell signaling in response to glutamate in Schwann cells. FASEB J.
2017, 31, 1744–1755. [CrossRef] [PubMed]
96. Fernandez-Montoya, J.; Buendia, I.; Martin, Y.B.; Egea, J.; Negredo, P.; Avendano, C. Sensory
Input-Dependent Changes in Glutamatergic Neurotransmission- Related Genes and Proteins in the Adult
Rat Trigeminal Ganglion. Front. Mol. Neurosci. 2016, 9, 132. [CrossRef] [PubMed]
97. Boyce, S.; Wyatt, A.; Webb, J.K.; O’Donnell, R.; Mason, G.; Rigby, M.; Sirinathsinghji, D.; Hill, R.G.;
Rupniak, N.M. Selective NMDA NR2B antagonists induce antinociception without motor dysfunction:
Correlation with restricted localisation of NR2B subunit in dorsal horn. Neuropharmacology 1999, 38, 611–623.
[CrossRef]
98. Fernández-Montoya, J. Mecanismos Moleculares y Celulares Implicados en la Respuesta del Sistema
Trigeminal Periférico a Alteraciones Inducidas en la Entrada Sensorial. Ph.D. Thesis, Neuroscience,
Universidad Autonoma de Madrid, Madrid, Spain, 2017.
99. Azkue, J.J.; Murga, M.; Fernandez-Capetillo, O.; Mateos, J.M.; Elezgarai, I.; Benitez, R.; Osorio, A.; Diez, J.;
Puente, N.; Bilbao, A.; et al. Immunoreactivity for the group III metabotropic glutamate receptor subtype
mGluR4a in the superficial laminae of the rat spinal dorsal horn. J. Comp. Neurol. 2001, 430, 448–457.
[CrossRef]
100. Brumovsky, P.; Watanabe, M.; Hokfelt, T. Expression of the vesicular glutamate transporters-1 and -2 in
adult mouse dorsal root ganglia and spinal cord and their regulation by nerve injury. Neuroscience 2007, 147,
469–490. [CrossRef] [PubMed]
101. Rozanski, G.M.; Li, Q.; Stanley, E.F. Transglial transmission at the dorsal root ganglion sandwich synapse:
Glial cell to postsynaptic neuron communication. Eur. J. Neurosci. 2013, 37, 1221–1228. [CrossRef] [PubMed]
102. Mantuano, E.; Lam, M.S.; Shibayama, M.; Campana, W.M.; Gonias, S.L. The NMDA receptor functions
independently and as an LRP1 co-receptor to promote Schwann cell survival and migration. J. Cell Sci. 2015,
128, 3478–3488. [CrossRef] [PubMed]
103. Chen, T.J.; Frohlich, N.; Kula, B.; Barzan, R.; Kukley, M. Glutamate activates AMPA receptor conductance in
the developing Schwann cells of the mammalian peripheral nerves. J. Neurosci. 2017. [CrossRef] [PubMed]
104. Micu, I.; Plemel, J.R.; Lachance, C.; Proft, J.; Jansen, A.J.; Cummins, K.; van Minnen, J.; Stys, P.K. The
molecular physiology of the axo-myelinic synapse. Exp. Neurol. 2016, 276, 41–50. [CrossRef] [PubMed]
105. Boldyrev, A.A.; Kazey, V.I.; Leinsoo, T.A.; Mashkina, A.P.; Tyulina, O.V.; Johnson, P.; Tuneva, J.O.; Chittur, S.;
Carpenter, D.O. Rodent lymphocytes express functionally active glutamate receptors. Biochem. Biophys. Res.
Commun. 2004, 324, 133–139. [CrossRef] [PubMed]
106. Pacheco, R.; Ciruela, F.; Casado, V.; Mallol, J.; Gallart, T.; Lluis, C.; Franco, R. Group I metabotropic glutamate
receptors mediate a dual role of glutamate in T cell activation. J. Biol. Chem. 2004, 279, 33352–33358.
[CrossRef] [PubMed]
107. Pacheco, R.; Gallart, T.; Lluis, C.; Franco, R. Role of glutamate on T-cell mediated immunity. J. Neuroimmunol.
2007, 185, 9–19. [CrossRef] [PubMed]
108. Fallarino, F.; Volpi, C.; Fazio, F.; Notartomaso, S.; Vacca, C.; Busceti, C.; Bicciato, S.; Battaglia, G.;
Bruno, V.; Puccetti, P.; et al. Metabotropic glutamate receptor-4 modulates adaptive immunity and restrains
neuroinflammation. Nat. Med. 2010, 16, 897–902. [CrossRef] [PubMed]
109. Rimaniol, A.C.; Haik, S.; Martin, M.; Le Grand, R.; Boussin, F.D.; Dereuddre-Bosquet, N.; Gras, G.;
Dormont, D. Na+-dependent high-affinity glutamate transport in macrophages. J. Immunol. 2000, 164,
5430–5438. [CrossRef] [PubMed]
Int. J. Mol. Sci. 2018, 19, 69 22 of 24
110. Shanshiashvili, L.; Tsitsilashvili, E.; Dabrundashvili, N.; Kalandadze, I.; Mikeladze, D. Metabotropic
glutamate receptor 5 may be involved in macrophage plasticity. Biol. Res. 2017, 50, 4. [CrossRef] [PubMed]
111. Levite, M. Glutamate, T cells and multiple sclerosis. J. Neural Transm. 2017, 124, 775–798. [CrossRef]
[PubMed]
112. Hu, P.; McLachlan, E.M. Distinct functional types of macrophage in dorsal root ganglia and spinal nerves
proximal to sciatic and spinal nerve transections in the rat. Exp. Neurol. 2003, 184, 590–605. [CrossRef]
113. Austin, P.J.; Berglund, A.M.; Siu, S.; Fiore, N.T.; Gerke-Duncan, M.B.; Ollerenshaw, S.L.; Leigh, S.J.;
Kunjan, P.A.; Kang, J.W.; Keay, K.A. Evidence for a distinct neuro-immune signature in rats that develop
behavioural disability after nerve injury. J. Neuroinflamm. 2015, 12, 96. [CrossRef] [PubMed]
114. Zeng, Y.; Lv, X.; Zeng, S.; Shi, J. Activity-dependent neuronal control of gap-junctional communication in
fibroblasts. Brain Res. 2009, 1280, 13–22. [CrossRef] [PubMed]
115. Busija, D.W.; Bari, F.; Domoki, F.; Horiguchi, T.; Shimizu, K. Mechanisms involved in the cerebrovascular
dilator effects of cortical spreading depression. Prog. Neurobiol. 2008, 86, 379–395. [CrossRef] [PubMed]
116. Attwell, D.; Buchan, A.M.; Charpak, S.; Lauritzen, M.; Macvicar, B.A.; Newman, E.A. Glial and neuronal
control of brain blood flow. Nature 2010, 468, 232–243. [CrossRef] [PubMed]
117. Hall, C.N.; Reynell, C.; Gesslein, B.; Hamilton, N.B.; Mishra, A.; Sutherland, B.A.; O’Farrell, F.M.;
Buchan, A.M.; Lauritzen, M.; Attwell, D. Capillary pericytes regulate cerebral blood flow in health and
disease. Nature 2014, 508, 55–60. [CrossRef] [PubMed]
118. Collard, C.D.; Park, K.A.; Montalto, M.C.; Alapati, S.; Buras, J.A.; Stahl, G.L.; Colgan, S.P. Neutrophil-derived
glutamate regulates vascular endothelial barrier function. J. Biol. Chem. 2002, 277, 14801–14811. [CrossRef]
[PubMed]
119. Xiao, H.S.; Huang, Q.H.; Zhang, F.X.; Bao, L.; Lu, Y.J.; Guo, C.; Yang, L.; Huang, W.J.; Fu, G.; Xu, S.H.; et al.
Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of
neuropathic pain. Proc. Natl. Acad. Sci. USA 2002, 99, 8360–8365. [CrossRef] [PubMed]
120. Yang, L.; Zhang, F.X.; Huang, F.; Lu, Y.J.; Li, G.D.; Bao, L.; Xiao, H.S.; Zhang, X. Peripheral nerve injury
induces trans-synaptic modification of channels, receptors and signal pathways in rat dorsal spinal cord.
Eur. J. Neurosci. 2004, 19, 871–883. [CrossRef] [PubMed]
121. Zimmermann, M. Pathobiology of neuropathic pain. Eur. J. Pharmacol. 2001, 429, 23–37. [CrossRef]
122. Zhou, S.; Bonasera, L.; Carlton, S.M. Peripheral administration of NMDA, AMPA or KA results in pain
behaviors in rats. Neuroreport 1996, 7, 895–900. [CrossRef] [PubMed]
123. Jin, Y.H.; Yamaki, F.; Takemura, M.; Koike, Y.; Furuyama, A.; Yonehara, N. Capsaicin-induced glutamate
release is implicated in nociceptive processing through activation of ionotropic glutamate receptors and
group I metabotropic glutamate receptor in primary afferent fibers. J. Pharmacol. Sci. 2009, 109, 233–241.
[CrossRef] [PubMed]
124. Zhuo, M. Ionotropic glutamate receptors contribute to pain transmission and chronic pain. Neuropharmacology
2017, 112, 228–234. [CrossRef] [PubMed]
125. Malet, M.; Brumovsky, P.R. VGLUTs and Glutamate Synthesis-Focus on DRG Neurons and Pain. Biomolecules
2015, 5, 3416–3437. [CrossRef] [PubMed]
126. Christoph, T.; Reissmuller, E.; Schiene, K.; Englberger, W.; Chizh, B.A. Antiallodynic effects of NMDA
glycine(B) antagonists in neuropathic pain: Possible peripheral mechanisms. Brain Res. 2005, 1048, 218–227.
[CrossRef] [PubMed]
127. Tan, P.H.; Chia, Y.Y.; Chow, L.H.; Chen, J.J.; Yang, L.C.; Hung, K.C.; Chen, H.S.; Kuo, C.H. Gene knockdown
of the N-methyl-D-aspartate receptor NR1 subunit with subcutaneous small interfering RNA reduces
inflammation-induced nociception in rats. Anesthesiology 2010, 112, 1482–1493. [CrossRef] [PubMed]
128. Feldman, D.E.; Knudsen, E.I. Experience-dependent plasticity and the maturation of glutamatergic synapses.
Neuron 1998, 20, 1067–1071. [CrossRef]
129. Crawford, D.C.; Mennerick, S. Presynaptically silent synapses: Dormancy and awakening of presynaptic
vesicle release. Neuroscientist 2012, 18, 216–223. [CrossRef] [PubMed]
130. Hanse, E.; Seth, H.; Riebe, I. AMPA-silent synapses in brain development and pathology. Nat. Rev. Neurosci.
2013, 14, 839–850. [CrossRef] [PubMed]
131. Chung, S.; Jeong, J.H.; Ko, S.; Yu, X.; Kim, Y.H.; Isaac, J.T.R.; Koretsky, A.P. Peripheral Sensory Deprivation
Restores Critical-Period-like Plasticity to Adult Somatosensory Thalamocortical Inputs. Cell Rep. 2017, 19,
2707–2717. [CrossRef] [PubMed]
Int. J. Mol. Sci. 2018, 19, 69 23 of 24
132. Haas, K.; Li, J.; Cline, H.T. AMPA receptors regulate experience-dependent dendritic arbor growth in vivo.
Proc. Natl. Acad. Sci. USA 2006, 103, 12127–12131. [CrossRef] [PubMed]
133. Hickmott, P.W.; Ethell, I.M. Dendritic plasticity in the adult neocortex. Neuroscientist 2006, 12, 16–28.
[CrossRef] [PubMed]
134. Zhu, J.J.; Esteban, J.A.; Hayashi, Y.; Malinow, R. Postnatal synaptic potentiation: Delivery of GluR4-containing
AMPA receptors by spontaneous activity. Nat. Neurosci. 2000, 3, 1098–1106. [CrossRef] [PubMed]
135. Holtmaat, A.J.; Trachtenberg, J.T.; Wilbrecht, L.; Shepherd, G.M.; Zhang, X.; Knott, G.W.; Svoboda, K.
Transient and persistent dendritic spines in the neocortex in vivo. Neuron 2005, 45, 279–291. [CrossRef]
[PubMed]
136. De Paola, V.; Holtmaat, A.; Knott, G.; Song, S.; Wilbrecht, L.; Caroni, P.; Svoboda, K. Cell type-specific
structural plasticity of axonal branches and boutons in the adult neocortex. Neuron 2006, 49, 861–875.
[CrossRef] [PubMed]
137. Qiao, Q.; Ma, L.; Li, W.; Tsai, J.W.; Yang, G.; Gan, W.B. Long-term stability of axonal boutons in the mouse
barrel cortex. Dev. Neurobiol. 2016, 76, 252–261. [CrossRef] [PubMed]
138. Diamond, M.E.; Armstrong-James, M.; Ebner, F.F. Experience-dependent plasticity in adult rat barrel cortex.
Proc. Natl. Acad. Sci. USA 1993, 90, 2082–2086. [CrossRef] [PubMed]
139. Rema, V.; Armstrong-James, M.; Jenkinson, N.; Ebner, F.F. Short exposure to an enriched environment
accelerates plasticity in the barrel cortex of adult rats. Neuroscience 2006, 140, 659–672. [CrossRef] [PubMed]
140. Kolb, B.; Gorny, G.; Soderpalm, A.H.; Robinson, T.E. Environmental complexity has different effects on the
structure of neurons in the prefrontal cortex versus the parietal cortex or nucleus accumbens. Synapse 2003,
48, 149–153. [CrossRef] [PubMed]
141. Machin, R.; Perez-Cejuela, C.G.; Bjugn, R.; Avendano, C. Effects of long-term sensory deprivation on
asymmetric synapses in the whisker barrel field of the adult rat. Brain Res. 2006, 1107, 104–110. [CrossRef]
[PubMed]
142. Gelfo, F.; De Bartolo, P.; Giovine, A.; Petrosini, L.; Leggio, M.G. Layer and regional effects of environmental
enrichment on the pyramidal neuron morphology of the rat. Neurobiol. Learn. Mem. 2009, 91, 353–365.
[CrossRef] [PubMed]
143. Negredo, P.; Martin, Y.B.; Lagares, A.; Castro, J.; Villacorta, J.A.; Avendano, C. Trigeminothalamic barrelette
neurons: Natural structural side asymmetries and sensory input-dependent plasticity in adult rats.
Neuroscience 2009, 163, 1242–1254. [CrossRef] [PubMed]
144. Landers, M.S.; Knott, G.W.; Lipp, H.P.; Poletaeva, I.; Welker, E. Synapse formation in adult barrel cortex
following naturalistic environmental enrichment. Neuroscience 2011, 199, 143–152. [CrossRef] [PubMed]
145. Oberlaender, M.; Ramirez, A.; Bruno, R.M. Sensory experience restructures thalamocortical axons during
adulthood. Neuron 2012, 74, 648–655. [CrossRef] [PubMed]
146. Schubert, V.; Lebrecht, D.; Holtmaat, A. Peripheral deafferentation-driven functional somatosensory map
shifts are associated with local, not large-scale dendritic structural plasticity. J. Neurosci. 2013, 33, 9474–9487.
[CrossRef] [PubMed]
147. Cheetham, C.E.; Barnes, S.J.; Albieri, G.; Knott, G.W.; Finnerty, G.T. Pansynaptic enlargement at adult cortical
connections strengthened by experience. Cereb. Cortex 2014, 24, 521–531. [CrossRef] [PubMed]
148. Martin, Y.B.; Negredo, P.; Villacorta-Atienza, J.A.; Avendano, C. Trigeminal intersubnuclear neurons:
Morphometry and input-dependent structural plasticity in adult rats. J. Comp. Neurol. 2014, 522, 1597–1617.
[CrossRef] [PubMed]
149. Allen, C.B.; Celikel, T.; Feldman, D.E. Long-term depression induced by sensory deprivation during cortical
map plasticity in vivo. Nat. Neurosci. 2003, 6, 291–299. [CrossRef] [PubMed]
150. Takahashi, T.; Svoboda, K.; Malinow, R. Experience strengthening transmission by driving AMPA receptors
into synapses. Science 2003, 299, 1585–1588. [CrossRef] [PubMed]
151. Dachtler, J.; Hardingham, N.R.; Glazewski, S.; Wright, N.F.; Blain, E.J.; Fox, K. Experience-dependent
plasticity acts via GluR1 and a novel neuronal nitric oxide synthase-dependent synaptic mechanism in adult
cortex. J. Neurosci. 2011, 31, 11220–11230. [CrossRef] [PubMed]
152. Gierdalski, M.; Jablonska, B.; Smith, A.; Skangiel-Kramska, J.; Kossut, M. Deafferentation induced changes
in GAD67 and GluR2 mRNA expression in mouse somatosensory cortex. Brain Res. Mol. Brain Res. 1999, 71,
111–119. [CrossRef]
153. Hebb, D.O. The Organization of Behavior. A Neuropsychological Theory; Wiley: New York, NY, USA, 1949.
Int. J. Mol. Sci. 2018, 19, 69 24 of 24
154. Diamond, M.C.; Krech, D.; Rosenzweig, M.R. The Effects of an Enriched Environment on the Histology of
the Rat Cerebral Cortex. J. Comp. Neurol. 1964, 123, 111–120. [CrossRef] [PubMed]
155. Andin, J.; Hallbeck, M.; Mohammed, A.H.; Marcusson, J. Influence of environmental enrichment on
steady-state mRNA levels for EAAC1, AMPA1 and NMDA2A receptor subunits in rat hippocampus.
Brain Res. 2007, 1174, 18–27. [CrossRef] [PubMed]
156. Valles, A.; Boender, A.J.; Gijsbers, S.; Haast, R.A.; Martens, G.J.; de Weerd, P. Genomewide analysis of rat
barrel cortex reveals time- and layer-specific mRNA expression changes related to experience-dependent
plasticity. J. Neurosci. 2011, 31, 6140–6158. [CrossRef] [PubMed]
157. Staiger, J.F.; Masanneck, C.; Bisler, S.; Schleicher, A.; Zuschratter, W.; Zilles, K. Excitatory and inhibitory
neurons express c-Fos in barrel-related columns after exploration of a novel environment. Neuroscience 2002,
109, 687–699. [CrossRef]
158. Rampon, C.; Jiang, C.H.; Dong, H.; Tang, Y.P.; Lockhart, D.J.; Schultz, P.G.; Tsien, J.Z.; Hu, Y. Effects of
environmental enrichment on gene expression in the brain. Proc. Natl. Acad. Sci. USA 2000, 97, 12880–12884.
[CrossRef] [PubMed]
159. Tang, Y.P.; Wang, H.; Feng, R.; Kyin, M.; Tsien, J.Z. Differential effects of enrichment on learning and memory
function in NR2B transgenic mice. Neuropharmacology 2001, 41, 779–790. [CrossRef]
160. Bender, K.J.; Allen, C.B.; Bender, V.A.; Feldman, D.E. Synaptic basis for whisker deprivation-induced synaptic
depression in rat somatosensory cortex. J. Neurosci. 2006, 26, 4155–4165. [CrossRef] [PubMed]
161. Kubota, J.; Mikami, Y.; Kanemaru, K.; Sekiya, H.; Okubo, Y.; Iino, M. Whisker experience-dependent mGluR
signaling maintains synaptic strength in the mouse adolescent cortex. Eur. J. Neurosci. 2016, 44, 2004–2014.
[CrossRef] [PubMed]
162. Turrigiano, G.G.; Leslie, K.R.; Desai, N.S.; Rutherford, L.C.; Nelson, S.B. Activity-dependent scaling of
quantal amplitude in neocortical neurons. Nature 1998, 391, 892–896. [CrossRef] [PubMed]
163. Urban-Ciecko, J.; Wen, J.A.; Parekh, P.K.; Barth, A.L. Experience-dependent regulation of presynaptic
NMDARs enhances neurotransmitter release at neocortical synapses. Learn. Mem. 2014, 22, 47–55. [CrossRef]
[PubMed]
164. Banerjee, A.; Larsen, R.S.; Philpot, B.D.; Paulsen, O. Roles of Presynaptic NMDA Receptors in
Neurotransmission and Plasticity. Trends Neurosci. 2016, 39, 26–39. [CrossRef] [PubMed]
165. Bragina, L.; Bonifacino, T.; Bassi, S.; Milanese, M.; Bonanno, G.; Conti, F. Differential expression of
metabotropic glutamate and GABA receptors at neocortical glutamatergic and GABAergic axon terminals.
Front. Cell. Neurosci. 2015, 9, 345. [CrossRef] [PubMed]
166. Cahusac, P.M.; Wan, H. Group II metabotropic glutamate receptors reduce excitatory but not inhibitory
neurotransmission in rat barrel cortex in vivo. Neuroscience 2007, 146, 202–212. [CrossRef] [PubMed]
167. Hokfelt, T.; Zhang, X.; Wiesenfeld-Hallin, Z. Messenger plasticity in primary sensory neurons following
axotomy and its functional implications. Trends Neurosci. 1994, 17, 22–30. [CrossRef]
168. Fu, S.Y.; Gordon, T. The cellular and molecular basis of peripheral nerve regeneration. Mol. Neurobiol. 1997,
14, 67–116. [CrossRef] [PubMed]
169. Vogelaar, C.F.; Hoekman, M.F.; Gispen, W.H.; Burbach, J.P. Homeobox gene expression in adult dorsal root
ganglia during sciatic nerve regeneration: Is regeneration a recapitulation of development? Eur. J. Pharmacol.
2003, 480, 233–250. [CrossRef] [PubMed]
170. Krames, E.S. The dorsal root ganglion in chronic pain and as a target for neuromodulation: A review.
Neuromodulation 2015, 18, 24–32; discussion 32. [CrossRef] [PubMed]
171. Fernandez-Montoya, J.; Martin, Y.B.; Negredo, P.; Avendano, C. Changes in the axon terminals of primary
afferents from a single vibrissa in the rat trigeminal nuclei after active touch deprivation or exposure to an
enriched environment. Brain Struct. Funct. 2017. [CrossRef] [PubMed]
© 2017 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
